Travere Therapeutics, Inc.
Travere Therapeutics, Inc.
TVTX
Valuace
93
Růst
93
Zdraví
50
Cena
$ 33.60
Dnes
--0.53 (-1.87%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
3.0B
Obrat
0B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
0%
ROA
0%
PE
-48
PS
5
Cena 1R
13-42
⌀ Cena
23.31
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
19-02-2026
Poslední dividenda

Profil

Travere Therapeutics, Inc., biofarmaceutická společnost, se zaměřuje na identifikaci, vývoj, komercializaci a poskytování terapií pro léčbu vzácných onemocnění. Mezi její výrobky uváděné na trh patří Chenodal, syntetická perorální forma kyseliny chenodeoxycholové pro léčbu radiolucentních kamenů ve žlučnících; Cholbam, tobolka kyseliny cholové pro léčbu pediatrických a dospělých pacientů s poruchami syntézy žlučových kyselin způsobenými defekty jednoho enzymu, stejně jako pro podpůrnou léčbu pacientů s peroxisomálními poruchami; a Thiola a Thiola EC, tableta tioproninu pro léčbu homozygotní cystinurie. Výrobky společnosti se také skládají ze Sparsentanu, který je ve fázi III klinické studie léčby fokální segmentální glomerulosklerózy a imunoglobulinové A nefropatie, a TVT-058, nového výzkumného humánního enzymového substituenta, který je ve fázi I/II klinických studií pro léčbu klasické homocystinurie. Má dohodu o spolupráci v oblasti výzkumu a vývoje s Národním centrem zdravotnictví pro rozvoj translačních věd a organizací pro obhajobu pacientů, CDG Care a Aliancí pro Alagillův syndrom pro identifikaci potenciálních malých molekulárních léků pro nedostatek NGLY1 a Alagillův syndrom. Společnost byla dříve známá jako Retrophin, Inc. a v listopadu 2020 změnila své jméno na Travere Therapeutics, Inc. Společnost Travere Therapeutics, Inc. byla založena v roce 2008 a sídlí v San Diegu v Kalifornii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
385
Založení
2012-11-08
Adresa
3611 Valley Centre Drive
CEO
Eric M. Dube

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues490.7490.7233.2145.2212.0227.5198.3175.3164.2154.9133.699.928.20.00.00.00.0
Cost of Revenues28.571.17.711.57.66.86.15.25.53.64.62.20.60.00.00.00.0
Gross Profit462.3419.6225.4133.8204.4220.7192.2170.1158.7151.3129.097.727.60.00.00.00.0
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues129.7164.9114.481.774.862.954.141.445.137.1
Cost of Revenues20.71.61.54.72.61.612.41.516.41.3
Gross Profit109.0163.3112.977.172.261.341.739.928.635.8
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.00.00.0245.0235.8210.3131.8141.0123.878.270.950.447.87.10.00.00.0
Selling General & Admin Expenses0.00.00.0265.5220.2149.9135.8129.0103.7104.098.079.559.616.930.30.00.0
Depreciation & Amortization60.760.743.638.57.32.26.430.118.717.816.113.45.40.20.10.00.0
Total Operating Expenses525.1482.5549.3521.9456.0360.2267.6269.9227.4182.1168.9130.0107.424.030.30.00.0
Operating Income-62.8-62.8-323.8-376.7-251.6-139.5-75.4-99.8-80.0-53.8-58.2-50.7-79.8-24.0-30.20.00.0
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.058.760.6
Selling General & Admin Expenses0.00.00.00.00.00.00.00.052.767.8
Depreciation & Amortization18.115.814.012.812.111.210.39.911.911.5
Total Operating Expenses141.4138.3125.6119.7133.0117.4108.8179.1111.5129.7
Operating Income-32.424.9-12.7-42.7-60.7-56.1-67.1-139.2-82.8-89.2
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income12.712.717.821.86.32.05.010.15.50.00.00.00.00.00.00.00.0
Interest Expense10.810.711.211.311.320.119.118.89.81.234.57.755.019.50.10.00.0
Other Expense13.613.63.30.6-26.6-40.2-113.4-46.6-28.9-26.4-17.0146.1-21.4-9.70.00.00.0
IBT-49.3-49.3-320.5-376.1-278.2-179.7-188.8-146.4-101.9-58.4-57.6105.5-113.4-33.7-30.30.00.0
Income Tax Expense1.01.00.10.20.30.4-19.40.00.81.4-9.7-11.8-2.50.10.00.00.0
Net Income-50.3-50.3-321.5-111.4-278.5-180.1-169.4-146.4-102.7-59.7-47.9117.2-110.9-33.8-30.30.00.0
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income2.63.03.33.83.83.64.46.07.25.8
Interest Expense2.32.82.82.92.82.82.82.82.82.8
Other Expense11.40.8-0.11.50.41.3-2.53.5-5.73.4
IBT-21.125.7-12.7-41.2-60.3-54.8-69.6-135.8-88.5-89.2
Income Tax Expense0.90.00.00.0-0.1-0.10.10.20.10.0
Net Income-22.025.7-12.8-41.2-60.3-54.8-70.4-136.1-90.2150.7
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$-1.50$-4.37$-3.01$-3.56$-3.46$-2.54$-1.54$-1.29$3.49$-4.43$-2.38$-8.29$-0.14$0.00
EPS Diluted$0.00$0.00$0.00$-1.50$-4.37$-3.01$-3.56$-3.46$-2.54$-1.54$-1.25$3.17$-4.43$-2.38$-8.29$-0.14$0.00
Shares Outstanding90.389.278.974.363.859.847.542.340.438.837.033.625.114.23.70.10.0
Diluted Shares Outstanding90.389.278.974.363.859.847.542.340.438.838.337.625.114.23.70.10.0
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-1.18$-0.99
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-1.18$-0.99
Shares Outstanding90.389.288.988.483.177.877.577.176.576.3
Diluted Shares Outstanding90.3102.688.988.483.177.877.577.176.576.3
Current Assets TTM 202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents32.358.558.261.7165.884.862.4102.999.441.037.818.26.00.00.00.0
Short Term Investments293.1312.2508.7388.6387.1276.8336.1368.7201.2214.9191.89.60.10.00.00.0
Total Cash & ST Investments325.4370.7566.9450.2552.9361.6398.5471.5300.6255.9229.627.86.10.00.00.0
Accounts Receivable27.327.121.216.616.233.118.014.513.965.459.38.00.00.00.00.0
Inventory6.06.29.46.97.37.66.15.65.42.82.50.80.00.00.00.0
Other Current Assets10.312.719.312.66.58.16.44.06.08.310.50.81.40.00.00.0
Total Current Assets369.0416.7616.8486.4582.8410.4429.1495.7325.8332.4301.937.37.50.00.00.0
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents110.975.261.958.536.432.343.358.2144.270.9
Short Term Investments143.6244.4260.3312.2241.0293.1397.8508.7490.4420.5
Total Cash & ST Investments254.5319.5322.2370.7277.4325.4441.0566.9634.6491.3
Accounts Receivable83.038.734.427.125.224.522.721.214.620.4
Inventory5.54.13.96.26.46.04.59.420.818.8
Other Current Assets28.017.213.612.715.813.112.819.316.211.6
Total Current Assets371.1379.6374.2416.7324.7369.0481.1616.8686.2542.1
Long-Term Assets TTM 202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment23.019.625.530.034.39.42.93.13.22.60.40.70.10.00.00.0
Goodwill0.80.80.80.90.90.90.90.90.90.90.90.90.00.00.00.0
Intangible Assets104.4103.2103.7145.0148.4153.2157.2186.7184.8182.0161.594.312.62.20.00.0
Long-Term Investments0.00.00.00.00.00.00.015.00.0-6.421.2-140.8-2,600.70.00.00.0
Other Long-Term Assets53.953.842.211.111.133.514.77.75.67.42.01.90.00.10.00.0
Total Long-Term Assets182.1177.4172.1186.1193.8197.0175.7213.5194.5192.9210.598.113.02.40.00.0
Total Assets551.1594.1788.9672.6776.6607.4604.8709.2520.3525.3512.4135.520.52.40.00.0
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment15.816.918.019.621.823.024.225.526.828.1
Goodwill0.00.80.80.80.70.80.80.80.80.9
Intangible Assets109.4104.9103.1103.2103.5104.4100.4103.7106.9153.5
Long-Term Investments0.00.00.00.00.00.00.00.00.00.0
Other Long-Term Assets42.353.252.853.853.653.957.142.112.911.8
Total Long-Term Assets167.5175.7174.6177.4179.7182.2182.5172.1146.6194.3
Total Assets538.6555.3548.8594.1504.4551.1663.5788.9832.9736.4
Current Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Accounts Payable25.823.541.717.315.112.126.67.018.97.57.67.13.61.00.00.0
Short-Term Debt5.274.19.84.43.90.00.022.50.00.00.040.50.00.90.00.0
Other Current Liabilities84.9100.3119.3108.588.880.568.825.566.775.778.231.031.71.40.00.0
Current Liabilities121.3200.8177.9142.2124.192.795.4104.685.783.385.8107.535.25.80.10.0
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable18.219.115.423.523.225.816.741.724.719.9
Short-Term Debt5.774.474.274.173.95.25.09.89.69.3
Other Current Liabilities111.196.092.9100.389.184.9145.0119.396.296.2
Current Liabilities135.1189.5182.5200.8190.0121.3173.2177.9139.4135.7
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Long-Term Debt378.1327.5399.9403.1258.1215.3204.9195.145.144.443.943.30.00.00.00.0
Capital Leases19.922.627.531.935.40.00.00.00.00.00.00.00.00.00.00.0
Def. Tax Liability0.00.00.00.00.00.00.00.00.06.424.30.12.60.00.00.0
Total Liabilities536.0535.0588.1629.7474.5396.2383.6390.9227.2217.5212.4172.738.85.80.10.0
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt324.0325.1326.2327.5328.5398.1399.0399.9424.6426.6
Capital Leases18.419.721.022.623.925.126.322.628.629.8
Def. Tax Liability0.00.00.00.00.00.00.022.60.00.0
Total Liabilities465.0522.6516.0535.0534.9536.0589.5588.1553.1619.9
Total Common Equity TTM 202420232022202120202019201820172016201520142013201220112010
Common Stock0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Retained Earnings-1,332.1-1,447.2-1,125.6-1,014.2-766.0-585.9-416.4-270.0-177.7-113.1-65.2-179.2-67.4-33.6-0.10.0
Comprehensive Income-1.6-0.1-1.5-2.9-0.6-0.90.7-1.5-1.0-0.5-0.74.3-0.10.00.00.0
Total Common Equity15.159.1200.842.9302.1211.2221.2318.3293.1307.8300.0-37.3-18.3-3.4-0.10.0
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.00.00.00.00.00.00.00.00.00.0
Retained Earnings-1,475.4-1,501.1-1,488.4-1,447.2-1,386.9-1,332.1-1,261.7-1,125.6-1,035.4-1,186.2
Comprehensive Income-1.1-0.8-0.8-0.1-1.0-1.6-1.9-1.5-3.7-3.9
Total Common Equity73.632.732.859.1-30.515.174.1200.8279.8116.5
Other TTM 202420232022202120202019201820172016201520142013201220112010
Total Debt403.2401.6404.8407.5262.0215.3204.9217.545.144.443.983.80.00.90.00.0
Book Value15.159.1200.842.9302.1211.2221.2318.3293.1307.8300.0-37.3-18.3-3.4-0.10.0
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value73.632.732.859.1-30.515.174.1200.8279.8116.5
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income-410.1-25.5-320.6-376.3-278.5-180.1-169.4-146.4-102.7-59.7-47.9117.2-110.9-33.8-30.30.00.0
Depreciation & Amortization37.760.743.638.533.126.624.620.418.717.816.113.45.40.20.10.00.0
Stock-Based Compensation38.644.936.944.239.230.823.621.119.826.929.125.915.91.417.60.00.0
Change Working Capital-60.1-14.0-63.0-25.50.980.0-26.02.711.13.85.5-11.412.31.53.10.00.0
Change In Accounts Receivable-10.8-27.8-6.0-11.3-0.7-0.12.3-5.20.24.9-6.1-4.5-8.00.00.00.00.0
Change In Accounts Payable6.6-0.1-17.624.82.32.8-6.09.3-2.72.79.73.420.32.80.70.00.0
Change In Inventories-29.65.0-3.8-39.4-2.1-1.8-5.1-2.0-2.8-1.7-0.3-1.2-0.30.00.00.00.0
Other Non-cash Items189.6-28.365.739.019.023.8102.52.77.925.118.3-130.133.913.06.80.00.0
Cash from Operations-288.90.00.0-280.0-186.3-14.8-42.7-58.2-25.07.4-1.6-0.6-45.8-17.6-2.70.00.0
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-22.025.7-12.8-41.2-60.3-54.8-69.7-136.1-88.6-115.8
Depreciation & Amortization18.115.814.012.812.111.210.39.911.95.6
Stock-Based Compensation0.011.310.611.59.28.09.99.88.110.7
Change Working Capital52.7-37.3-5.6-23.77.4-6.7-60.7-2.97.1-3.6
Change In Accounts Receivable27.8-44.2-4.3-7.2-2.0-0.7-1.7-1.5-8.00.4
Change In Accounts Payable6.2-1.13.1-8.31.0-2.99.2-24.817.35.0
Change In Inventories1.20.20.03.7-0.3-0.2-1.4-1.8-22.4-4.0
Other Non-cash Items11.9-1.1-1.3-1.6-4.2-0.369.90.4100.4-5.7
Cash from Operations0.00.00.00.00.00.00.00.0-70.5-59.1
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-29.50.00.0-0.7-28.6-24.2-119.8-15.6-19.7-14.0-11.9-7.0-4.0-5.5-1.20.00.0
Acquisitions18.20.00.00.00.019.1113.115.4-15.0-13.1-0.5-33.4-29.2-5.40.00.00.0
Investments-218.3-237.1-125.8-443.9-385.4-547.1-215.0-223.7-331.3-102.4-184.1-198.5-18.0-7.00.00.00.0
Sales of Investment354.7323.6326.3334.6382.0433.6273.5259.1162.8114.5159.510.014.08.60.00.00.0
Other Investing Activities118.40.00.0165.8-0.6-19.1-113.1-15.40.060.647.4148.4-0.14.0-0.50.00.0
Cash from Investing249.90.00.055.8-32.6-137.6-61.319.9-203.345.610.4-80.6-37.3-5.4-1.70.00.0
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-18.9-15.2-0.20.0-9.618.4-12.0-6.5-5.5-5.6
Acquisitions0.00.00.00.00.00.00.00.012.65.6
Investments-167.9-4.8-64.40.0-125.80.00.00.0-62.6-155.6
Sales of Investment82.4106.681.453.255.054.3105.6111.450.087.7
Other Investing Activities0.00.00.00.00.00.00.00.0-11.4201.2
Cash from Investing0.00.00.00.00.00.00.00.0-17.0133.3
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid0.00.00.00.0-211.30.00.00.0-40.20.00.0-45.0-31.3-0.90.00.00.0
Debt Issued-2.9401.6-3.2-2.7356.846.610.5-12.7212.70.70.55.1115.10.00.90.00.0
Issuance of Common Stock2.40.00.0191.219.5224.9131.50.00.00.00.0149.540.030.93.50.00.0
Repurchase of Common Stock0.00.00.00.00.02.12.00.00.00.00.00.0-2.3-1.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.00.00.0-93.70.00.00.00.0
Other Financing Activities-1.60.00.027.6309.44.6-5.9-2.1272.15.4-5.7-3.7182.5-0.11.00.00.0
Cash from Financing-0.30.00.0218.8117.6231.7127.7-2.1231.95.4-5.7100.895.329.04.40.00.0
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.00.00.0
Debt Issued329.7-69.8-0.9-1.1-0.9-0.8-0.8-0.8-0.7-0.7
Issuance of Common Stock0.00.00.00.00.00.00.00.00.90.2
Repurchase of Common Stock0.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.00.1-0.6
Cash from Financing0.00.00.00.00.00.00.00.00.1-0.6
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash-38.634.50.4-3.5-104.181.022.3-40.43.558.43.219.612.26.00.00.00.0
Closing Cash Balance32.393.058.558.261.7165.884.862.4102.999.441.037.818.26.00.00.00.0
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash-17.935.813.33.422.14.1-11.0-14.9-86.173.4
Closing Cash Balance93.0110.975.261.958.536.432.343.358.2144.2
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow-318.437.8-338.7-322.3-214.8-38.9-162.6-73.8-44.7-6.6-13.5-7.6-49.8-23.1-3.90.00.0
Real Free Cash Flow-357.0-7.1-375.6-366.5-254.0-69.7-186.2-94.9-64.4-33.5-42.6-33.5-65.7-24.6-21.50.00.0
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow61.114.24.7-54.0-45.3-50.7-52.2-125.5-76.0-64.7
Real Free Cash Flow61.12.9-5.9-65.5-54.5-58.7-62.2-135.2-84.1-75.4
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-48.2-8.8-1.4
P/S4.95.69.4
P/B32.912.25.2
P/FCF-327.3-15.2-1.5
Market cap$3.0$1.3
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0 %121 %0 %
Debt to Income-656.1 %-316 %0 %
Debt to Free cash flow-4453.7 %-198137.1 %0 %
Interest expense percentage-17.1 %-25.9 %44.7 %
Current ratio2.7 2.9 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-68.3 %3205.8 %0 %
ROA-9.3 %-74.8 %0 %
CapEx to Revenue7 %336.8 %0 %
RaD to Revenue0 %811.9 %0 %
ROEM1,274,620.8 408245.4

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin94.2 %71.2 %68.7 %
Operating margin-12.8 %-2250.7 %35.5 %
Net margin-10.2 %-5664.2 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %-2 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding90.3 mil 41.0 mil
Employee count0.4 tis 0.2 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader